NRX Pharmaceuticals Inc. (NASDAQ: NRXP) Stock Information | RedChip

NRX Pharmaceuticals Inc. (NASDAQ: NRXP)


$3.3500
+0.6600 ( +14.73% ) 2.3M

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Market Data


Open


$3.3500

Previous close


$2.6900

Volume


2.3M

Market cap


$33.50M

Day range


$2.6650 - $3.4350

52 week range


$1.1000 - $7.3330

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Aug 20, 2024
8-k 8K-related 20 Aug 15, 2024
8-k 8K-related 25 Aug 14, 2024
10-q Quarterly Reports 71 Aug 14, 2024
8-k 8K-related 14 Aug 12, 2024
8-k 8K-related 14 Jun 27, 2024
3 Insider transactions 1 Jun 26, 2024
8-k 8K-related 15 Jun 20, 2024
8-k 8K-related 15 May 23, 2024
8-k 8K-related 17 May 16, 2024

Latest News